1-10 of 10 results for subject:Screening
Librarians' tools
- Search time
- 0.18 seconds
- Solr query time
- 0.006 seconds
- Search query
- subject:Screening
- We searched for
- subject_t:Screening OR subject_ses:92923
Type
House
Session
Year
Department
More
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
The Conservative Government introduced the hugely successful opt-out HIV and hepatitis testing programme for A&Es in London, Brighton, Blackpool and Manchester, with a £20 million commitment to expand the programme to 33 more, diagnosing more than 1,300 people with HIV in the first two years and tackling health inequalities. This has meant, crucially, that more LGBT+ people, women, people of black African ethnicity and older people have been diagnosed and supported. Will the Minister assure the House that the funding and commitment will remain?
The Conservative Government introduced the hugely successful opt-out HIV and hepatitis testing programme for A&Es in London, Brighton, Blackpool and Manchester, with a £20 million commitment to expand the programme to 33 more, diagnosing more than 1,300 people with HIV in the first two years and tackling health inequalities. This has meant, crucially, that more LGBT+ people, women, people of black African ethnicity and older people have been diagnosed and supported. Will the Minister assure the House that the funding and commitment will remain?
I thank the hon. Lady for raising such an important issue, on which all Members across the House want to make progress. Officials are working on further plans, which we will set out very shortly, but we will be keen to work with her and colleagues across the House to make sure that we eradicate new HIV and AIDS infections.
I thank the hon. Lady for raising such an important issue, on which all Members across the House want to make progress. Officials are working on further plans, which we will set out very shortly, but we will be keen to work with her and colleagues across the House to make sure that we eradicate new HIV and AIDS infections.
I thank the hon. Lady for raising such an important issue, on which all Members across the House want to make progress. Officials are working on further plans, which we will set out very shortly, but we will be keen to work with her and colleagues across the House to make sure that we eradicate new HIV and AIDS infections.
The Conservative Government introduced the hugely successful opt-out HIV and hepatitis testing programme for A&Es in London, Brighton, Blackpool and Manchester, with a £20 million commitment to expand the programme to 33 more, diagnosing more than 1,300 people with HIV in the first two years and tackling health inequalities. This has meant, crucially, that more LGBT+ people, women, people of black African ethnicity and older people have been diagnosed and supported. Will the Minister assure the House that the funding and commitment will remain?
To ask the Minister for Women and Equalities, whether she has had discussions with the Secretary of State for Health and Social Care on the potential merits of extending opt-out HIV testing on a nationwide basis.
To ask the Minister for Women and Equalities, whether she has had discussions with the Secretary of State for Health and Social Care on the potential merits of extending opt-out HIV testing on a nationwide basis.
Equality Ministers maintain a keen interest in the delivery of the Government’s HIV Action Plan, which sets out the ambitious plan to achieve zero new HIV infections in England by 2030 and an interim target of an 80% reduction in new infections by 2025.
The HIV Action Plan sets out how DHSC will maintain progress made with key groups, and significantly improve diagnosis for other groups.
The previous Minister for Equalities, Mike Freer, recently met Professor Kevin Fenton, Regional Director for London in the Office for Health Improvement and Disparities, Chief Advisor on HIV and Chair of the HIV Action Plan Implementation Steering Group, to discuss implementation of the HIV Action Plan and how it links to the Government’s ambitions on improving outcomes for LGBT people.
NHS England and NHS Improvement is investing £20 million over the next three years to expand opt-out testing in emergency departments in the highest prevalence local areas to identify new cases of HIV. High prevalence is defined as those areas with five or more cases per 1,000 residents in line with guidance from the National Institute for Health and Care Excellence. DHSC Ministers would be able to respond to more detailed questions.
What advice would the Minister give to women, including my daughter, who recently signed a petition seeking to make smear tests routinely available to women under 25?
What advice would the Minister give to women, including my daughter, who recently signed a petition seeking to make smear tests routinely available to women under 25?
My answer will be similar to that which I gave to the hon. Member for Washington and Sunderland West (Mrs Hodgson) on Question 1. Clinical decisions are taken with regard to age range, but whatever age is set, there will always be people who fall outside it—in this case those younger than 25. What is critical is that people know what is normal for them and what symptoms they should be worried about. The Under-Secretary of State for Health and Social Care, my hon. Friend the Member for Thurrock (Jackie Doyle-Price), who has responsibility for women’s health issues and inequalities, is doing great work with her new taskforce on women’s health to identify what a safe period looks like and examine issues such as menopause so that women and girls everywhere really understand when they should be concerned about something and seek help.
My answer will be similar to that which I gave to the hon. Member for Washington and Sunderland West (Mrs Hodgson) on Question 1. Clinical decisions are taken with regard to age range, but whatever age is set, there will always be people who fall outside it—in this case those younger than 25. What is critical is that people know what is normal for them and what symptoms they should be worried about. The Under-Secretary of State for Health and Social Care, my hon. Friend the Member for Thurrock (Jackie Doyle-Price), who has responsibility for women’s health issues and inequalities, is doing great work with her new taskforce on women’s health to identify what a safe period looks like and examine issues such as menopause so that women and girls everywhere really understand when they should be concerned about something and seek help.
My answer will be similar to that which I gave to the hon. Member for Washington and Sunderland West (Mrs Hodgson) on Question 1. Clinical decisions are taken with regard to age range, but whatever age is set, there will always be people who fall outside it—in this case those younger than 25. What is critical is that people know what is normal for them and what symptoms they should be worried about. The Under-Secretary of State for Health and Social Care, my hon. Friend the Member for Thurrock (Jackie Doyle-Price), who has responsibility for women’s health issues and inequalities, is doing great work with her new taskforce on women’s health to identify what a safe period looks like and examine issues such as menopause so that women and girls everywhere really understand when they should be concerned about something and seek help.
What advice would the Minister give to women, including my daughter, who recently signed a petition seeking to make smear tests routinely available to women under 25?
To ask the Minister for Women and Equalities, if she will hold discussions with the Secretary of State for Health on making the NHS cervical screening programme available to women aged 18 years and over.
To ask the Minister for Women and Equalities, if she will hold discussions with the Secretary of State for Health on making the NHS cervical screening programme available to women aged 18 years and over.
The best independent evidence shows that routine screening of women under 25 actually does more harm than good. Cervical cancer in women under the age of 25 is very rare and younger women often undergo natural and harmless changes in the cervix that screening would identify as abnormalities, resulting in many false negatives.
We offer vaccination to girls to protect against the Human Papilloma Virus (HPV) which protects against 70 per cent of cervical cancers and which is expected to reduce the already low rates of cervical cancer in these young women and allow them to be protected for years to come.
Young women with symptoms of cervical cancer, largely unusual bleeding particularly after sex, should see their GP and be referred to a gynecologist if clinically appropriate.
My Rt Hon Friend the Minister for Women and Equalities has no plans to discuss this issue with the Secretary of State for Health and Social Care.
What recent discussions she has had with the Secretary of State for Health and Social Care on the adequacy of the breast cancer screening programme.
What recent discussions she has had with the Secretary of State for Health and Social Care on the adequacy of the breast cancer screening programme.
Our breast cancer screening programme provides a world-leading service, inviting more than 2.5 million women for a test each year, detecting cancer earlier and saving lives.
Our breast cancer screening programme provides a world-leading service, inviting more than 2.5 million women for a test each year, detecting cancer earlier and saving lives.
Our breast cancer screening programme provides a world-leading service, inviting more than 2.5 million women for a test each year, detecting cancer earlier and saving lives.
What recent discussions she has had with the Secretary of State for Health and Social Care on the adequacy of the breast cancer screening programme.
The independent breast screening review found that a lack of clarity over when women should receive their invitations had caused the error that resulted in 67,000 women not being invited to their final breast screening. Will the Government implement the review’s recommendations and introduce guidance to clarify the ages at which women should be invited for routine screening?
The independent breast screening review found that a lack of clarity over when women should receive their invitations had caused the error that resulted in 67,000 women not being invited to their final breast screening. Will the Government implement the review’s recommendations and introduce guidance to clarify the ages at which women should be invited for routine screening?
The hon. Gentleman is right. The review found that the breast screening incident that was made public in May had arisen because of a lack of alignment between the national service specification and the way in which the programme was being run in practice. As a result, NHS England has announced a comprehensive review of cancer screening programmes, to be undertaken by Professor Sir Mike Richards. We will take account of the findings of both that review and our own breast screening review to ensure that changes improve the whole system.
The hon. Gentleman is right. The review found that the breast screening incident that was made public in May had arisen because of a lack of alignment between the national service specification and the way in which the programme was being run in practice. As a result, NHS England has announced a comprehensive review of cancer screening programmes, to be undertaken by Professor Sir Mike Richards. We will take account of the findings of both that review and our own breast screening review to ensure that changes improve the whole system.
The hon. Gentleman is right. The review found that the breast screening incident that was made public in May had arisen because of a lack of alignment between the national service specification and the way in which the programme was being run in practice. As a result, NHS England has announced a comprehensive review of cancer screening programmes, to be undertaken by Professor Sir Mike Richards. We will take account of the findings of both that review and our own breast screening review to ensure that changes improve the whole system.
The independent breast screening review found that a lack of clarity over when women should receive their invitations had caused the error that resulted in 67,000 women not being invited to their final breast screening. Will the Government implement the review’s recommendations and introduce guidance to clarify the ages at which women should be invited for routine screening?